Sundaram Clayton Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

Results View source PDF Explain this filing

SUNCLAY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.3%Reaction day

₹1204.90

prior close

₹1182.30

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%+1.6% vs market

Auto Components & Equipments peers, median of 109sector-0.7%+1.9% vs sector

On the reaction day the stock moved 1.6 pts more than Nifty Microcap 250 and 1.9 pts more than its Auto Components & Equipments peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.5

10m

-0.8

15m

-0.9

30m

+1.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.3-0.4+1.6-0.7+1.9

Next day

+3.4+1.4+2.0+0.5+2.9

+2.1+0.2+2.0+0.0+2.1

+9.6+3.9+5.7+3.2+6.3

+10.1+5.2+4.8+5.4+4.6

+9.1+4.2+4.9+5.3+3.8

+11.6+6.0+5.6+7.5+4.1

15d

+12.6+3.5+9.1+5.8+6.9

+14.6-0.7+15.3+1.7+13.0

-1.3-9.9+8.6-12.1+10.8

+12.7+9.9+2.8+6.1+6.6

UpDownMarket · Nifty Microcap 250Sector · Auto Components & Equipments peers, median of 109Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sundaram Clayton Limited has submitted its financial results for the period ended December 31, 2025 (Q3 FY26) to the stock exchange. The filing is a standard compliance disclosure and no specific financial figures, segment performance, or management commentary have been provided in this notice. Investors will need to refer to the detailed results PDF for the actual numbers on revenue, profit, margins, and other key metrics.

Likely market impact

This is a routine regulatory filing and by itself has no direct impact on the stock price. The actual results contained in the submission will determine whether the stock reacts positively or negatively.